You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 6, June 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Skin Manifestations of Mustard Gas

A Clinical Study of 535 Patients Exposed to Mustard Gas

Ali-Z Momeni, MD; Shahla Enshaeih, MD; Montaza Meghdadi, MD; Maliheh Amindjavaheri, MD

Arch Dermatol. 1992;128(6):775-780.


Abstract

• Background.—
During the Iraq-Iran war (1980-1988), 535 patients who were exposed to mustard gas (one of the chemical warfare agents used by Iraq) were referred to our dermatology department. In this article, we have tried to review the skin manifestations of these patients.

Observations.—
The skin lesions were of early or late onset. The early onset lesions consisted of erythema (76%), bulla (55%), and purpura (1.1%). These lesions were mostly found on the face and skin folds. The late-onset manifestations were pigmentation (20.4%) and desquamation (11.2%). Other complications were ophthalmic (85%), pulmonary (15%), and gastrointestinal (10%). Lymphopenia (7%) was the most serious laboratory disorder reported. Biopsy specimens of the lesions showed subepidermal bullae with mild dermal and epidermal necrosis.

Conclusions.—
All patients were treated as for burns using sulfadiazine and furacine. All patients were cured in a period of 15 to 45 days. During a 6-month follow-up, no mortality was observed.

(Arch Dermatol. 1992;128:775-780)



Author Affiliations

From the Department of Dermatology, Isfahan (Iran) University of Medical Sciences.


Footnotes

Accepted for publication March 2, 1992.

Reprint requests to PO Box 1191, Isfahan, Iran (Dr Momeni).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity
Kumar et al.
Hum Exp Toxicol 2002;21:371-376.
ABSTRACT  

Analytic Reviews: Management of Patients Exposed to Biological and Chemical Warfare Agents
Marik and Bowles
J Intensive Care Med 2002;17:147-161.
ABSTRACT  

The Role of the Clinical Laboratory in Managing Chemical or Biological Terrorism
Jortani et al.
Clin. Chem. 2000;46:1883-1893.
ABSTRACT | FULL TEXT  

Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK-14 human keratinocytes in vitro
Smith et al.
Hum Exp Toxicol 1997;16:247-253.
ABSTRACT  

Assessment of the biochemical effects of percutaneous exposure of sulphur mustard in an in vitro human skin system
Lindsay and Rice
Hum Exp Toxicol 1996;15:237-244.
ABSTRACT  

Severe Cutaneous Reactions to Self-Defense Sprays
Parneix-Spake et al.
Arch Dermatol 1993;129:913-913.
ABSTRACT  

Epidermal Hyperplasia With or Without Atypia in Patients Exposed to Mustard Gas
Dowlati et al.
Arch Dermatol 1993;129:245-245.
ABSTRACT  

Epidermal Hyperplasia With or Without Atypia in Patients Exposed to Mustard Gas-Reply
Momeni
Arch Dermatol 1993;129:245-245.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.